2% mupirocin ointment applied intra-nasally for 5 days was assessed for elimination of nasal carriage of Staphylococcus aureus in 31 staff members in a children's hospital. Three volunteers failed to complete the trial because of side effects, i.e. buccal reddening and swelling, and unpleasant taste. During treatment staphylococcal nasal carriage was not found in any case; of the 24 post-treatment nasal swabs taken 4 days after treatment 22 were still negative. Re-colonization with S. aureus of different phage types occurred in the remaining two cases.
Introduction
first recorded the antibacterial activit'y of a group of substances produced by fermentation of a strain of Pseudomonasfluorescens. Subsequently, the name pseudomonic acid A was ascribed to the major metabolite, which accounted for most of the antibacterial activity observed. Mupirocin has been accepted as the approved name for pseudomonic acid A. Its chemical structure and mode of action has been shown to be different from any known class of antibiotics (Chain & Mellows, 1977; Hughes & Mellows 1978 a,b; Alexander et al., 1985 et al., 1985) . Casewell & Hill (1985 , 1986 One hundred and eighty-six medical and nursing staff working in clinical areas of a children's hospital were screened for nasal and pharyngeal carriage of S. aureus. The organism was isolated from 63 (33.9%), and 31 of these staff (nine males and 22 females), who were still positive after a repeat nasal swab at 1 week, were enrolled in the study. Informed consent was obtained from each subject.
The topical treatment consisted of pseudomonic acid A 2% w/w as calcium salt in an ointment base of soft paraffin containing anhydrous lanolin (Beecham Pharmaceuticals, Worthing, England). Volunteers were given verbal and written instructions.
The ointment was applied in match-head size amounts to each nostril by fingertips. After application it was distributed by squeezing the nose between finger and thumb. The ointment was given four times a day for 5 days.
The persistence of staphylococcal carriage prior to treatment was confirmed by examination of a third nasal and pharyngeal swab. On the third day of treatment another swab was taken. Follow-up nasal swabs were collected 1 and 4 days after each course.
All nasal swabs were collected in a standard way by firmly rotating plain cotton-wool swabs, soaked in sterilized physiologic saline, around the periphery of the anterior nares. In the present study, mupirocin has been shown promptly to eliminate nasal carriage of S. uureus. As suggested in previous studies (Dacre, Emmerson & Jenner, 1983; Casewell & Hill, 1986) , this topical agent has an important role in the elimination of nasal staphylococci. During a small outbreak of gentamicin-and methicillin-resistant S. uureus on a urology ward, mupirocin was found to be effective in eradicating the multiresistant micro-organism in 15 nasal carriers (Dacre, et al., 1983) . However, the formulation in polyethylene glycol was associated with side effects such as localized stinging, soreness, dry skin and itching around the nose, noticed by six of the subjects.
In Casewell & Hill's study (1986) of 32 healthy volunteers, no significant side-effects were observed with a white soft paraffin base formulation.
In their study S. uwem could not be detected, even in low numbers, in nose swabs from any of the volunteers within 2 days of starting mupirocin, and even after 5 weeks only six showed recolonization.
Ultimately, 14 individuals resumed staphylococcal carriage, in most cases with different phage types. Similarly encouraging results were found in our study. Elimination of S. uzweza from the anterior nares could be found on day 3 of therapy in all subjects from whom swabs were available.
One week after starting the treatment recolonization was noted in only two subjects. Unfortunately, further follow-up could not be carried out. However, the prompt eradication of nasal carriage by mupirocin within 3 days of treatment was impressive, and gave further evidence that it may be useful in controlling staphylococcal outbreaks in hospitals.
